30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Product / Company Performance

K2M Reports Preliminary 2016/4Q16 Revenue -

K2M announced preliminary 2016 sales in the range of US $236.1MM to $236.6MM, and a 4Q16 sales range of $61.3MM to $61.8MM. (U.S. +21%, ex-U.S. -7%)

For 4Q16, approximate U.S. segment YoY growth is expected to be:

  • Complex Spine +17%
  • Minimally Invasive Spine +35%
  • Degenerative +18%

The company expects to grow 2017 revenue in the mid-teens.

Source: K2M, Inc.

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.